As the National Aeronautics and Space Administration (NASA) progresses its ambitious Artemis spaceflight program, Australian researchers including the Kolling Institute’s Academic Director Professor James Elliott will tap into their scientific expertise to offer support. Professor Elliott attended a recent event at NASA’s Johnson Space Centre in Texas, which brought together leading clinicians and .....
Read more

The strength of interdisciplinary research across the Northern Sydney (Arabanoo) Precinct was highlighted during a dynamic showcase at the Kolling Institute. The annual event, which has been steadily lifting its profile, featured the latest research progress across allied health, nursing, medicine, as well as pharmacy, dentistry and public health. More than a hundred people attended this year’s eve.....
Read more

Researchers from the Kolling Institute have led an international study investigating why some people spontaneously recover from whiplash following a motor vehicle collision, while others don’t. Their work has uncovered new evidence indicating it may relate to the health of muscles and stress. More than 140 people were recruited to the longitudinal study, which involved research teams from the Unite.....
Read more

A $400,000 robot which may hold the key to significant improvements in hip and knee replacements is now operational at the Kolling Institute. Known as KOBRA or the Kolling Orthopaedic Biomechanics Robotic Arm, the new technology delivers an advanced testing facility, while greatly increasing research capabilities. It is the largest of its kind in Australia and one of just two SimVitro robots in the.....
Read more

Clinicians, researchers and patients have welcomed a landmark law which will pave the way for remarkable new IVF technology to prevent mitochondrial disease. Known as “Maeve’s law” after a young Victorian girl with a rare genetic disorder, the legislation was passed by Federal Parliament allowing the specialised IVF procedure to be carried out in Australia. It will involve replacing faulty mitochon.....
Read more

The Kolling is set to be one of the first institutes in New South Wales to introduce new world-leading technology, boosting our cancer and neuroscience research capabilities. The Digital Spatial Profiling System has been made possible following a $535,000 grant from the Australian Research Council LIEF scheme. The project is being co-funded by the University of Sydney with a $250,000 contribution, .....
Read more

Researchers and clinicians have welcomed Federal Government funding to improve the diagnosis and treatment of high blood pressure. The condition affects around 1 in 3 people in Australia, significantly increasing the risk of stroke, coronary heart disease, heart failure and chronic kidney disease. Men are more likely to have uncontrolled high blood pressure, with 1 in 4 men suffering untreated high.....
Read more

The Neuroscience and Pain Research Showcase provided a timely opportunity to demonstrate the breadth of expertise across this priority research area at the Kolling. Co-ordinated by Professors Paul Glare and Lisa Harvey, the online event attracted more than 250 people. A diverse range of presentations focused on the cutting-edge research targeting mitochondrial disease, psychiatric disorders, spinal.....
Read more

New research is set to revolutionise the diagnosis and treatment of whiplash injuries, one of the most common and challenging injuries following a non-catastrophic motor vehicle collision. The longitudinal study, conducted over more than five years, involved researchers from the Kolling Institute along with scientists from Northwestern University, University of Colorado and Stanford University. Clo.....
Read more

Dr Cindy Shu will have a key role in building commercial capabilities at the Kolling after receiving a fellowship from the REDI (Researcher Exchange and Development within Industry) program. The program provides financial support to Australian and international medical technology and pharmaceutical companies to bring the best talent in-house to work on priority medical research projects. Cindy is o.....
Read more